Recent studies conducted in a plethora of cancers showed the success of CRISPR-Cas9 technology to effectively knock out the expression of HOTAIR, NEAT1, XIST, TUG1, and UCA1 and to effectively upregulate the expression of MEG3 [107]. The gene discussed is MEG3; the disease is cancer.